HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

ASTH

Astrana Health, Inc. (NASDAQ)

Healthcare — Medical Care Facilities

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.

None 9 analysts
$46.41
+$3.40 (+3.06%)
Target: $46.00 (-0.9%)
Sign in to add ASTH to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$2.30B
P/E Ratio (TTM)76.08
Forward P/E13.57
EPS (TTM)$0.61
Dividend Yield-
Profit Margin0.86%
Revenue Growth55.60%
ROE5.66%
Debt/Equity184.46
Recommendation None
Analyst Target$46.00
Analysts9
Indexes NASDAQ

Technical Indicators

RSI (14)85.3
Beta0.94
SMA 20-
SMA 40-
52-Week High$47.09
52-Week Low$18.08
50-Day Avg$37.61
200-Day Avg$28.66
Avg Volume527.7K
Volume$1.15M

Performance Analysis

BEARISH

ASTH is flashing more cautionary signals — investors should monitor closely.

- Trading near its 52-week high ($47.09), which may indicate limited upside.
- RSI at 85.3 indicates overbought conditions — a pullback may be due.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
- P/E of 76.1 is elevated — the market expects high growth or it may be overvalued.
+ Strong revenue growth of 55.6% year-over-year.
~ Wall Street consensus is "none" from 9 analysts.
- Average analyst target of $46.00 implies 0.9% downside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jun 30, 2026 21:07 UTC

Back to Screener Export Report